Joe Chang, Professor and Director at shared a post on X:
“So glad to participate in the MD Anderson Alumni Association meeting during the Japan Society of Clinical Oncology’s 2024 Annual Meeting. More then 100 Japanese oncologists have been trained at MDACC and they have moved into leadership positions.”
More posts featuring Joe Chang.
Joe Y. Chang, MD, PhD, FASTRO, is a tenured Professor and Director of the Stereotactic Ablative Radiotherapy (SABR) Program at MD Anderson Cancer Center. Named among “The Best Doctors in America,” he chairs the ACR Thoracic Appropriateness Use Criteria Committee and the PTCOG thoracic subcommittee. He also serves on the NCCN Thoracic Guidelines Committee and the editorial boards of several medical journals.
